Skip to content

Perineal Repair Trial. Comparing different types of local anaesthetic for perineal repair following childbirth

Local anaesthetic for perineal repair following vaginal delivery: A randomised controlled trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000056190
Enrollment
210
Registered
2019-01-15
Start date
2019-02-04
Completion date
2019-08-01
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A single blinded, randomised controlled trial in women who sustain second degree vaginal tears, to assess whether the use of either Ropivacaine or Lignocaine with Adrenaline infiltration prior to vaginal-perineal repair results in either reduced blood loss or reduced pain compared to standard treatment with lignocaine.

Interventions

Randomisation of local anaesthetic used for local infiltration prior to repair of second degree vaginal-perineal tears. Local anaesthetic (arm 1, arm 2 or arm 3) will be administered by local subcutaneous infiltration to the vagina and perineum on a once-only basis by the health professional performing the repair (midwife, or obstetric resident / registrar), immediately prior to performing the repair. Vaginal-perineal repair will then be conducted as per institutional protocols. 3 Arms: Arm 1

Randomisation of local anaesthetic used for local infiltration prior to repair of second degree vaginal-perineal tears. Local anaesthetic (arm 1, arm 2 or arm 3) will be administered by local subcutaneous infiltration to the vagina and perineum on a once-only basis by the health professional performing the repair (midwife, or obstetric resident / registrar), immediately prior to performing the repair. Vaginal-perineal repair will then be conducted as per institutional protocols. 3 Arms: Arm 1 - Lignocaine 1% - 20mls Arm 2 - Ropivacaine 0.75% - 20mls Arm 3 - Lignocaine 1% with adrenaline 1 in 200,000 - 20mls

Sponsors

Royal Women's Hospital
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

Singleton pregnancy Vaginal delivery Second degree vaginal-perineal tear

Exclusion criteria

Epidural for delivery Current illicit drug use Coagulation disorder for use of anticoagulants Major labial tears

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026